MYC and glioblastoma: In addition, histone deacetylase inhibitors (vorinostat, panobinostat, and romidepsin) inhibit glycolysis in human GBM models by transcriptionally repressing c-Myc, with a shift to OXPHOS, activation of β-oxidation, and inhibition of FA synthesis [308].